Ads
related to: implantable device for atrial fibrillation success statistics chart by datewexnermedical.osu.edu has been visited by 10K+ users in the past month
262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464- Find a Doctor
Meet with our experts to diagnose
your symptoms and receive treatment
- Patient Testimonials
Hear from our patients
about their Ohio State experience
- Should I See a Heart Doc
Talk to your doc about your heart
and learn what to ask
- Prepare For Your Visit
What to bring to your visit
plus heart & vascular resources
- Find a Doctor
Search results
Results from the WOW.Com Content Network
More modern devices have software designed to attempt a discrimination between ventricular fibrillation and ventricular tachycardia (VT), and may try to pace the heart faster than its intrinsic rate in the case of VT, to try to break the tachycardia before it progresses to ventricular fibrillation. This is known as overdrive pacing, or anti ...
The DAVID trials [24] have shown that unnecessary pacing of the right ventricle can exacerbate heart failure and increases the incidence of atrial fibrillation. The newer dual-chamber devices can keep the amount of right ventricle pacing to a minimum and thus prevent worsening of the heart disease.
Defibrillation is a treatment for life-threatening cardiac arrhythmias, specifically ventricular fibrillation (V-Fib) and non-perfusing ventricular tachycardia (V-Tach). [1] [2] A defibrillator delivers a dose of electric current (often called a counter-shock) to the heart.
S-ICD lead and generator position. Subcutaneous implantable cardioverter defibrillator, or S-ICD, is an implantable medical device for detecting and terminating ventricular tachycardia and ventricular fibrillation in patients at risk of sudden cardiac arrest. [1]
An implantable loop recorder (ILR), also known as an insertable cardiac monitor (ICM), is a small device that is implanted under the skin of the chest for cardiac monitoring, to record the heart's electrical activity for an extended period.
A meta-analysis of 11 comparable studies with approximately 20,000 non-overlapping patients in different indications was published by Nguyen et al. [49] They found an overall mortality rate of 1.4%, a VT/VF rate of 2.6% and a VT/VF-related mortality rate of only 0.2% across all patients. 1.7% of the patients (9.1 patients/100 patient years) had ...
Ads
related to: implantable device for atrial fibrillation success statistics chart by datewexnermedical.osu.edu has been visited by 10K+ users in the past month
262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464